In episode 444, James and Mike wade into the evidence quagmire around hydroxychloroquine and COVID-19. The bottom line is the evidence will likely be different around the time you listen to the podcast. So listen quickly.
Show notes
1)Tools for Practice
Hydroxychloroquine with or without azithromycin for COVID-19
2) Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial
In episode 443, James and Mike continue with Mike Kolber and we discuss the evidence around electronic cigarettes and their use for smoking cessation. Overall, the podcast ends up being smoking hot in so many ways.
Show notes
Tools for Practice
Electronic Cigarettes – Hoot that helps, hurts, or just hype?
In episode 442, James and Mike welcome back Mike Kolber to discuss all the evidence around biosimilars. The issue is exactly the same one we have had for decades with the question around brand name versus generic medications. Tune in and find out the answer.
Show notes
Tools for Practice
It’s all in the details… or is it? Biosimilars versus biologics for inflammatory conditions
In episode 441, James and Mike revisit the problem with guidelines. We talk about recent writings on the issues around guidelines. We discuss the main problems and believe it or not we give advice and suggestions for how to make them better.
Show notes
1) Health Affair
Fixing Clinical Practice Guidelines
2) Evidence vs Consensus in Clinical Practice Guidelines
JAMA 2019 Jul 19. doi: 10.1001/jama.2019.9751
3) The future of guidelines: Primary care focused, patient oriented, evidence based and simplified
THE NUTRITION PROPOSITION BOOK
Check it out at nutritionproposition.com and think about picking up a copy on Amazon. All the evidence you ever wanted about nutrition and the only nutrition book that won’t tell you what to eat.
